Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Moinfar

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The British Journal of Surgery|February 20, 2021
PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trialF Fitzal, M Filipits, C Fesl, et al.
Breast (Edinburgh, Scotland)|May 28, 2019
Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancerC F Singer, M Filipits, S W Jahn, et al.
ESMO Open|January 5, 2021
A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohortP Dubsky, L Van't Veer, M Gnant, et al.
EJNMMI Research|April 20, 2016
32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016W Langsteger, A Rezaee, W Loidl, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The British Journal of Surgery|February 20, 2021
PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trialF Fitzal, M Filipits, C Fesl, et al.
Breast (Edinburgh, Scotland)|May 28, 2019
Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancerC F Singer, M Filipits, S W Jahn, et al.
ESMO Open|January 5, 2021
A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohortP Dubsky, L Van't Veer, M Gnant, et al.
EJNMMI Research|April 20, 2016
32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016W Langsteger, A Rezaee, W Loidl, et al.
Pageof 3